Development of high-precision cell therapies for treating cancer and autoimmune disease
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | ADAMS AND REESE, LLP |
2nd Quarter (Apr 1 - June 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| ADAMS AND REESE, LLP | 1 | — |
| Issue | Activities |
|---|---|
| Budget/Appropriations | 1 |
| Medical/Disease Research/Clinical Labs | 1 |